MBX Biosciences, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
MBX on Nasdaq
Industry
Pharmaceutical Preparations
Location
12406 Horesham Street, Carmel, IN

There are no Buy or Sell transactions made by insiders since 9/18/2023

MBX Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Bartram Chief Financial Officer Sep 12, 2024
Orbimed Advisors Llc Director, 10%+ Owner Sep 16, 2024
Frazier Life Sciences X, L.P. 10%+ Owner Sep 16, 2024
Steven Ryder Director Sep 12, 2024
Tiba Aynechi Director Sep 16, 2024
New Enterprise Associates 17, L.P. 10%+ Owner Sep 16, 2024
Patrick J. Heron Director, 10%+ Owner Sep 16, 2024
James M. Cornelius Director Sep 16, 2024
Forest Baskett 10%+ Owner Sep 16, 2024
Ali Behbahani 10%+ Owner Sep 16, 2024
Carmen Chang 10%+ Owner Sep 16, 2024
Anthony A. Florence Jr. 10%+ Owner Sep 16, 2024
Mohamad Makhzoumi 10%+ Owner Sep 16, 2024
Edward T. Mathers Director, 10%+ Owner Sep 16, 2024
Scott D. Sandell 10%+ Owner Sep 16, 2024
Paul Edward Walker 10%+ Owner Sep 16, 2024
Rick Yang 10%+ Owner Sep 16, 2024
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10%+ Owner Sep 16, 2024
Ora H. Pescovitz Director Sep 12, 2024
Carl L. Gordon Director, 10%+ Owner Sep 16, 2024
P. Kent Hawryluk President & CEO, Director Sep 16, 2024
Salomon Azoulay Chief Medical Officer Sep 12, 2024

Recent Insider Transactions by Companies or Individuals for MBX Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.